Blend Labs Inc (BLND) concluded trading on Wednesday at a closing price of $4.10, with 2.92 million shares of worth about $11.98 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 70.12% during that period and on August 21, 2024 the price saw a gain of about 5.13%. Currently the company’s common shares owned by public are about 240.26M shares, out of which, 188.55M shares are available for trading.
Stock saw a price change of 14.85% in past 5 days and over the past one month there was a price change of 25.38%. Year-to-date (YTD), BLND shares are showing a performance of 60.78% which increased to 241.67% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.03 but also hit the highest price of $4.22 during that period. The average intraday trading volume for Blend Labs Inc shares is 2.87 million. The stock is currently trading 28.57% above its 20-day simple moving average (SMA20), while that difference is up 45.04% for SMA50 and it goes to 62.19% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Blend Labs Inc (NYSE: BLND) currently have 240.26M outstanding shares and institutions hold larger chunk of about 36.30% of that.
The stock has a current market capitalization of $1.04B and its 3Y-monthly beta is at 1.14. It has posted earnings per share of -$0.48 in the same period. It has Quick Ratio of 3.41. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BLND, volatility over the week remained 7.79% while standing at 10.65% over the month.
Stock’s fiscal year EPS is expected to rise by 72.44% while it is estimated to increase by 126.58% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Canaccord Genuity on August 12, 2024 offering a Buy rating for the stock and assigned a target price range of between $3 and $4.75 to it. On December 20, 2023, Wells Fargo Upgrade their recommendations, while on November 14, 2022, Keefe Bruyette Upgrade their ratings for the stock with a price target of $2.25. Stock get an Underperform rating from Keefe Bruyette on July 25, 2022.
